Responses
Clinical and epidemiological research
Extended report
Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register
Compose a Response to This Article
Other responses
No responses have been published for this article.